HealthExec

HealthExec

Today's top leaders in healthcare organizations need to lead not just by words but through their actions, ensuring their organizations stay true to their vision, values, goals, and mission. HealthExec supports these leaders by helping them maintain a strong focus on the Institute for Healthcare Improvement's "Triple Aim." This approach aims to enhance the patient experience, improve overall health in the community, and lower individual healthcare costs.

National, Trade/B2B
English
Online/Digital

Outlet metrics

Domain Authority
48
Ranking

Global

#332452

United States

#77474

Health/Health

#1666

Traffic sources
Monthly visitors

Articles

  • 1 week ago | healthexec.com | Chad Van Alstin

    Earlier this month, news broke that the Digital Medicine Society launched a partnership with developers and academic organizations, including Duke University, Google Fitbit, UNC Chapel Hill, and others. The stated aim of the collaboration is to use technology to reduce deaths associated with opioid relapse and overdose by leveraging data from consumer wearables, both dedicated devices and health-monitoring applications on smartphones.

  • 1 week ago | healthexec.com | Chad Van Alstin

    Last week, U.S. Food and Drug Administration (FDA) Commissioner Martin Makary, MD, and the agency’s chief vaccine advisor, Vinay Prasad, MD, released a paper outlining proposed policy shifts in how COVID-19 boosters are approved. Now, the Centers for Disease Control and Prevention (CDC) is following suit, changing its recommendations regarding who should receive the vaccine in the first place. In a video posted on social media, Department of Health and Human Services (HHS) Secretary Robert F.

  • 2 weeks ago | healthexec.com | Chad Van Alstin

    The U.S. Food and Drug Administration (FDA) said it is aware that C.R. Bard Urology and Critical Care, a subsidiary of multinational medical device manufacturer BD, has alerted customers to an urgent update to use instructions on a line of esophagogastric balloon tamponade tubes, which are used to control bleeding in the esophagus and stomach.

  • 2 weeks ago | healthexec.com | Chad Van Alstin

    The Independent is reporting that lawsuits claiming the popular weight-loss medication Ozempic is causing blindness are piling up, with more than a dozen legal filings pending across the country. Broadly, patients are claiming to have developed non-arteritic anterior ischemic optic neuropathy (NAION), which coincided with taking semaglutide, the active ingredient in Ozempic and Wegovy, the two most popular brands of the drug.

  • 2 weeks ago | healthexec.com | Chad Van Alstin

    The Centers for Medicare & Medicaid Services (CMS) is proposing some changes to the Accountable Care Organization Realizing Equity, Access, and Community Health—ACO REACH—model, the government’s value-based Medicare initiative that supports providers that serve rural and low-income patient populations.